February 28, 2018
For some of the best minds in cardiac care, the successful treatment of atrial fibrillation has been a moving target. Until now. CANet’s Commercialization grant is funding the development of the Catheter Contact-Force Controller (CFC), a pioneering device that will result in more effective atrial fibrillation (AF) treatments, fewer repeat procedures, and lower healthcare costs....
Read More

About CANet

CANet is a Pan-Canadian multidisciplinary and multi-sectoral research and development network of investigators, well-positioned industry partners, patients, caregivers, and healthcare providers focused on arrhythmia research, technology development and commercialization, and digital transformation activities.